Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2007-03-06
2009-06-30
Aeder, Sean E (Department: 1642)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S024330
Reexamination Certificate
active
07553948
ABSTRACT:
Novel markers for ovarian cancer that are both sensitive and accurate. These markers are overexpressed and/or differentially expressed in ovarian cancer specifically, as opposed to normal ovarian tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis, in ovarian cancer. The markers of the present invention, alone or in combination, show a high degree of differential detection between ovarian cancer and non-cancerous states.
REFERENCES:
patent: 2004/0181048 (2004-09-01), Wang
patent: 2006/0046257 (2006-03-01), Pollock et al.
patent: WO 03/105758 (2003-12-01), None
Tockman et al (Cancer Res., 1992, 52:2711s-2718s).
Stratagene catalog (p. 118, 1997/1998).
Affymetrix, “GeneChip® Human Genome Arrays”, 4 pages.
Affymetrix, “Human Genome U133 Plus 2.0 Array”, http://www.affymetrix.com/products/arrays/specific/hgu133plus.affx, 2 pages.
Affymetrix, “Human Genome U133 Set”, http://www.affymetrix.com/products/arrays/specific/hgu133.affx 2 pages.
Affymetrix, “Human Genome U133A 2.0 Array”, http://www.affymetrix.com/products/arrays/specific/Hgu133av2.affx, 2 pages.
Barrett et al., “NCBI GEO: mining millions of expression profiles—database and tools”,Nucl. Acids Res., 33:D562-D566 (2005).
Bast, R., “Status of Tumor Markers in Ovarian Cancer Screening”,J. Clin. Oncol., 21(10):200s-205s (2003).
Boguski et al., “dbEST—database for ‘expressed sequence tags’”,Nat. Genet., 4:332-333 (1993).
CBS, “Instructions”, http://www.cbs.dtu.dk/services/TMHMM/TMHMM2.0b.guide.php, 3 pages, Oct. 29, 2003.
CBS, “Scientific Background”, http://www.cbs.dtu.dk/services/SignalP/background/prediction.php, 2 pages, May 6, 2004.
Ch,EMBnet.org, “TMpred—Prediction of Transmembrane Regions and Orientation”, http://www.ch.embnet.org/software/TMPRED—form.html, 1 page.
Edgar et al., “Gene Expression Omnibus: NCBI gene expression and hybridization array data repository”,Nucl. Acids Res., 30(1):207-210 (2002).
Fahrlander et al., “Amplifying DNA Probe Signals: A ‘Christmas Tree’ Approach”,Biotechnology, 6:1165-1168 (1988).
Hazkani-Covo et al., “Evolution of multicellularity in Metoza: comparative analysis of the subcellular localization of proteins in Saccharomyces, Drosophila and Caenorhabditis”,Cell Biol. Int'l, 28:171-178 (2004).
Hofmann et al., “A database of Membrane Spanning Protein Segments”,Biol. Chem., Abstract MF C-35, 374:166 (1993).
Komuro et al., “Surviving expression in ovarian carcinoma: correlation with apoptotic markers and prognosis”,Modern Pathol., 17:264 (2004).
Krogh et al., “Predicting Transmembrane Protein Topology with a Hidden Markov Model: Application to Complete Genomes”,J. Mol. Biol., 305:567-580 (2001).
Maggino et al., “Serum markers as prognostic factors in epithelial ovarian cancer: an overview”,Eur. J. Gynaec. Oncol., 21(1):64-69 (2000).
Meyer et al., “Role of tumor markers in monitoring epithelial ovarian cancer”,Brit. J. Cancer, 82(9):1535-1538 (2000).
NCBI, “Expressed Sequence Tags database”, http://www.ncbi.nlm.nih.gov/dbEST/, 2 pages, Jul. 11, 2000.
NCBI, “Genbank Overview”, http://www.ncbi.nlm.nih.gov/Genbank/GenbankOverview.html, 2 pages, Sep. 20, 2004.
NCBI, “Gene Expression Omnibus”, http://www.ncbi.nlm.nih.gov/projects/geo/, 1 page.
NCBI, “Geo Overview”, http://www.ncbi.nlm.nih.gov/projects/geo/info/overview.html, 5 pages.
NCBI, “tissue-specific pattern of mRNA expression”, http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE1133, 2 pages, Mar. 19, 2004.
Robertson et al., “Inhibins/activins as diagnostic markers for ovarian cancer”,Mol. Cell. Endocrinol., 191:97-103 (2002).
Sorek et al., “A novel algorithm for computational identification of contaminated EST libraries”,Nucl. Acids Res., 31(3):1067-1074 (2003).
Sorek et al., “Alu-Containing Exons are Alternatively Spliced”,Genome Res., 12:1060-1067 (2002).
Staibano et al., “Loss of oestrogen receptor β, high PCNA and p53 expression and aneuploidy as markers of worse prognosis in ovarian granulosa cell tumors”,Histopathology, 43:254-262 (2003).
Su et al., “A gene atlas of the mouse and human protein-encoding transcriptomes”,PNAS, 101(16):6062-6067 (2004).
Terry et al., “Blood and urine markers for ovarian cancer: A comprehensive review”,Disease Markers, 20:53-70 (2004).
Akiva Pinchas
Ayalon-Soffer Michal
Cohen Yossi
Cojocaru Gad S.
Dahary Dvir
Aeder Sean E
Compugen Ltd
Elrifi Ivor R.
Johnson David E.
Mintz Levin Cohn Ferris Glovsky and Popeo PC
LandOfFree
Nucleotide and amino acid sequences, and assays and methods... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleotide and amino acid sequences, and assays and methods..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleotide and amino acid sequences, and assays and methods... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4087087